ChicoAA-O, Moreno-FernándezJA-O, Fernández-GarcíaDA-O, SoláEA-O. The hybrid closed-loop system tandem t: lim X2™ with Control-IQ technology: Expert recommendations for better management and optimization. Diabetes Ther, 2024; 15(1):281–295.
2.
HaidarA, LegaultL, RaffrayM, et al.Comparison between closed-loop insulin delivery system (the Artificial Pancreas) and sensor-augmented pump therapy: A randomized-controlled crossover trial. Diabetes Technol Ther, 2021; 23(3):168–174.
3.
LeelarathnaL, DellwegS, MaderJK, et al.AP@home Consortium. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: Three-Center randomized crossover study. Diabetes Care, 2014; 37(7):1931–1937.
4.
WeingerK, BeverlyEA, SmaldoneAM. Diabetes self-care and the older adult. West J Nurs Res, 2014; 36(9):1272–1298.
5.
HuangES, SinclairA, ConlinPR, et al.The growing role of technology in the care of older adults with diabetes. Diabetes Care, 2023; 46(8):1455–1463.
6.
KirkmanMS, Briscoe VJ, Clark N, FlorezH, et al.Diabetes in older adults. [1935–5548 (Electronic)].
7.
KubilayE, TrawleyS, WardGM, et al.Lived experience of older adults with type 1 diabetes using closed-loop automated insulin delivery in a randomised trial. Diabet Med, 2023; 40(4):e15020.
8.
ZengA, XuE, BellT, BristowTL. 1215-P: Attitudes towards diabetes technology in older adults with diabetes. Diabetes, 2023; 72(Suppl 1).
9.
AlshattiA, BishopK. Overcoming barriers to technology in special groups. Practical Diabetes, 2023; 40(5):35–39a.
10.
BurtonDM, EnigkMG, LillyJW. Blood glucose meters and accessibility to blind and visually impaired people. J Diabetes Sci Technol, 2012; 6(2):242–245.
11.
AkturkHK, Snell-BergeonJ, ShahVN. Health care professionals’ perspectives on use of diabetes technologies for managing visually impaired patients with diabetes. J Diabetes Sci Technol, 2023; 17(6):1610–1613.
12.
HeinemannL, DrosselD, FreckmannG, KulzerB. Usability of medical devices for patients with diabetes who are visually impaired or blind. J Diabetes Sci Technol, 2016; 10(6):1382–1387.
13.
ReuschelW, UslanMM. Accessibility of insulin pump displays to people with low vision. J Diabetes Sci Technol, 2014; 8(1):192–193.
14.
UslanMM, BurtonDM, ClementsCW. Blood glucose meters that are accessible to blind and visually impaired persons. J Diabetes Sci Technol, 2008; 2(2):284–287.
15.
MaromL. Insulin pump access issues for visually impaired people with type 1 diabetes. Diabetes Res Clin Pract, 2010; 89(1):e13–e15.
16.
WilliamsAS, SchnarrenbergerPA. A comparison of dosing accuracy: visually impaired and sighted people using insulin pens. J Diabetes Sci Technol, 2010; 4(3):514–521.
17.
AlonsoGT, TrioloTM, AkturkHK, et al.Increased technology use associated with lower A1C in a large pediatric clinical population. Diabetes Care, 2023; 46(6):1218–1222.
18.
TrolioM, HamiltonK, SukhaiM. The impact of the current accessibility of insulin pumps on the lives of the visually impaired in Canada. JBIR, 2022; 12(1).
19.
PolonskyWH, HoodKK, LevyCJ, et al.Omnipod 5 Research Group. How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System. Diabetes Res Clin Pract, 2022; 190:109998.
20.
PintaudiBA-O, GironiI, MeneghiniE, et al.Advanced hybrid closed loop system use in elderly with type 1 diabetes: Effectiveness and safety in a prospective, observational, 1-year follow-up real-world study. Diabetes Obesity Metabolism, 2023; 25(7):2034–2037.
21.
Gómez MedinaAM, Parra PrietoDA, Henao CarrilloDC, et al.Characteristics associated with elevated time below range in elderly patients with type 1 diabetes using an automated insulin delivery system. J Diabetes Sci Technol, 2024:19322968241232659.
22.
SherrJL, LaffelLM, LiuJ, et al.Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: Results from a cross-sectional survey. Diabetes Care, 2024; 47(6):941–947.
23.
MohanV, JoshiS, MithalA, et al.Expert consensus recommendations on time in range for monitoring glucose levels in people with diabetes: An Indian perspective. Diabetes Ther, 2023; 14(2):237–249.
24.
TrawleyS, KwonHJ, VorginS, et al.Automated insulin delivery effects during driving among older adults with type 1 diabetes in a randomized trial. Diabetes Technol Ther, 2024.
25.
ToschiE, MunshiMN. Benefits and challenges of diabetes technology use in older adults. Endocrinol Metab Clin North Am, 2020; 49(1):57–67.
26.
OuchidaK, LachsMS. Not for doctors only: Ageism in healthcare. Jstor, 2015.
27.
KilleenOJ, De LottLB, ZhouY, et al.Population prevalence of vision impairment in US adults 71 years and older: The national health and aging trends study. JAMA Ophthalmol, 2023; 141(2):197–204.
28.
YauJW, Rogers SL, Kawasaki R, LamoureuxEL, et al.Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 2012; 35(3):556–564.
29.
DeCormier PloskyW, Ne’emanA, SilvermanBC, et al.Excluding people with disabilities from clinical research: Eligibility criteria lack clarity and justification. Health Aff (Millwood), 2022; 41(10):1423–1432.
30.
AkturkHK, Snell-BergeonJK, ShahVN. Continuous glucose monitor with siri integration improves glycemic control in legally blind patients with diabetes. Diabetes Technol Ther, 2021; 23(1):81–83.
31.
Darren BurtonCS, SwisherM. Diabetes and visual impairment: Are insulin pumps accessible? Access World, 2004.
32.
HeydarianNM, HughesAS, MoreraOF, et al.Perspectives of interactions with healthcare providers among patients who are blind. J Blind Innov Res, 2021; 11(2):10.5241/11–206.
